SCHEMBL17029036

SCHEMBL17029036

Cc1cn2cc(-c3cccc(Cl)c3)nc2c(Br)c1C(O)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.39
TP53 P04637 1/20 0.39
MAPK13 O15264 1/20 0.38
DYRK3 O43781 1/20 0.38
MAP4K4 O95819 1/20 0.38
FYN P06241 1/20 0.38
PIM1 P11309 1/20 0.38
FGFR1 P11362 1/20 0.38
SRC P12931 1/20 0.38
CSNK1D P48730 1/20 0.38
CLK2 P49760 1/20 0.38
GSK3B P49841 1/20 0.38
BLK P51451 1/20 0.38
CSNK2A1 P68400 1/20 0.38
STK3 Q13188 1/20 0.38
CAMK2B Q13554 1/20 0.38
DYRK1A Q13627 1/20 0.38
PIM3 Q86V86 1/20 0.38
HIPK2 Q9H2X6 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17029024 0.89 SMN1; SMN2 (0.39) SMN1; SMN2TP53MAPK13DYRK3MAP4K4
SCHEMBL17029026 0.89 SMN1; SMN2 (0.39) SMN1; SMN2TP53MAPK13DYRK3MAP4K4
SCHEMBL17029055 0.84 CYP3A4 (0.36) SMN1; SMN2TP53
SCHEMBL17029008 0.83 KMO (0.43) SMN1; SMN2TP53MAPK13DYRK3MAP4K4
SCHEMBL18364985 0.79 CNR2 (0.38) SMN1; SMN2TP53MAPK13DYRK3MAP4K4
SCHEMBL17039242 0.79 CNR2 (0.38) SMN1; SMN2TP53MAPK13DYRK3MAP4K4
SCHEMBL20344785 0.79 CNR2 (0.38) SMN1; SMN2TP53MAPK13DYRK3MAP4K4
SCHEMBL17029010 0.78 NPC1 (0.41) SMN1; SMN2TP53MAPK13DYRK3MAP4K4
SCHEMBL17029013 0.77 F2RL3 (0.40) SMN1; SMN2TP53MAPK13DYRK3MAP4K4
SCHEMBL17039247 0.76 KDM4E (0.40) SMN1; SMN2TP53MAPK13DYRK3MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3107913-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION VIIV HEALTHCARE (NO.5) LIMITED (GB) 2016-12-28 EP disclosed
WO-2015126765-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2015-08-27 WO disclosed